Evidence map›Paper›PMID 29880027›Full record

ArticleGenome medicine2018

A computational tool to detect DNA alterations tailored to formalin-fixed paraffin-embedded samples in cancer clinical sequencing.

Mamoru Kato, Hiromi Nakamura, Momoko Nagai, Takashi Kubo, Asmaa Elzawahry, Yasushi Totoki, Yuko Tanabe, Eisaku Furukawa, Joe Miyamoto, Hiromi Sakamoto and 11 more

Open access · goldAbstract read
In one paragraph

Article in Genome medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 1 country.

Mamoru KatoDepartment of Bioinformatics, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan.ORCID 0000-0002-8485-8316
Hiromi NakamuraDivision of Cancer Genomics, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan.
Momoko NagaiDepartment of Bioinformatics, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan.
Takashi KuboDepartment of Clinical Genomics, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan.
Asmaa ElzawahryDepartment of Bioinformatics, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan.
Yasushi TotokiDivision of Cancer Genomics, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan.
Yuko TanabeDepartment of Experimental Therapeutics, National Cancer Center Hospital, Chuo-ku, Tokyo, 104-0045, Japan.
Eisaku FurukawaDepartment of Bioinformatics, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan.
Joe MiyamotoDepartment of Bioinformatics, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan.
Hiromi SakamotoDivision of Genetics, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan.
Shingo MatsumotoDivision of Translational Genomics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, 277-8577, Japan.
Kuniko SunamiDivision of Genome Biology, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan.
Yasuhito AraiDivision of Cancer Genomics, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan.
Yutaka SuzukiDepartment of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa-shi, Chiba, 277-8568, Japan.
Teruhiko YoshidaDivision of Genetics, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan.
Katsuya TsuchiharaDivision of Translational Genomics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, 277-8577, Japan.
Kenji TamuraDepartment of Experimental Therapeutics, National Cancer Center Hospital, Chuo-ku, Tokyo, 104-0045, Japan.
Noboru YamamotoDepartment of Experimental Therapeutics, National Cancer Center Hospital, Chuo-ku, Tokyo, 104-0045, Japan.
Hitoshi IchikawaDepartment of Clinical Genomics, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan.
Takashi KohnoDivision of Genome Biology, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan.
Tatsuhiro ShibataDivision of Cancer Genomics, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan.
National Cancer Centre Japan · JPChiba Cancer Center · JPThe University of Tokyo · JP

Funding

CREST-JST 14531766Japan Agency for Medical Research and Development 15ck0106012h0002Japan Agency for Medical Research and Development 15ck0106117h0002National Cancer Center Research and Development Funds 24-A-1National Cancer Center Research and Development Funds 25-A-6National Cancer Center Research and Development Funds 26-A-3National Cancer Center Research and Development Funds 27-A-1
6 · The paper itself

Abstract

Advanced cancer genomics technologies are now being employed in clinical sequencing, where next-generation sequencers are used to simultaneously identify multiple types of DNA alterations for prescription of molecularly targeted drugs. However, no computational tool is available to accurately detect DNA alterations in formalin-fixed paraffin-embedded (FFPE) samples commonly used in hospitals. Here, we developed a computational tool tailored to the detection of single nucleotide variations, indels, fusions, and copy number alterations in FFPE samples. Elaborated multilayer noise filters reduced the inherent noise while maintaining high sensitivity, as evaluated in tumor-unmatched normal samples using orthogonal technologies. This tool, cisCall, should facilitate clinical sequencing in everyday diagnostics. It is available at https://www.ciscall.org .

Indexed as

Paraffin EmbeddingCell Line, TumorComputational BiologyDNA Copy Number VariationsFormaldehydeHigh-Throughput Nucleotide SequencingHumansNeoplasmsFormaldehyde

Identifiers

PMID29880027
PMCPMC5992758
OpenAlexW2807255899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.